QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
For
the quarterly period ended September
30, 2007
|
Delaware
|
22-2786081
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
No.)
|
|
4
West Rockland Road
Montchanin,
Delaware
|
19710
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Class
|
Outstanding
at November 16, 2007
|
|
Common
Stock, $0.01 par value per share
|
10,231,143
shares
|
Item
1.
|
Financial
Statements
|
|
Unaudited
Consolidated Financial Statements:
|
||
Consolidated
Balance Sheets as of December 31, 2006 and September 30,
2007
|
1
|
|
Consolidated
Statements of Operations for the three and nine month periods ended
September 30, 2006 and 2007
|
2
|
|
Consolidated
Statement of Changes in Shareholders’ Equity for the nine month period
ended September 30, 2007
|
3
|
|
Consolidated
Statements of Cash Flows for the three and nine month periods ended
September 30, 2006 and 2007
|
4
|
|
Notes
to Consolidated Financial Statements
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
18
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
30
|
Item
4T.
|
Controls
and Procedures
|
30
|
PART
II. Other Information
|
||
Item
1.
|
Legal
Proceedings
|
31
|
Item
1A.
|
Risk
Factors
|
31
|
Item
6.
|
Exhibits
|
32
|
Signatures
|
33
|
ASSETS
|
As
of
December
31,
2006
|
As
of
September
30,
2007
|
|||||
(unaudited)
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
1,521
|
$
|
4,196
|
|||
Accounts
receivable, net
|
1,373
|
1,804
|
|||||
Unbilled
work-in-process
|
393
|
507
|
|||||
Other
current assets
|
316
|
542
|
|||||
Total
current assets
|
3,603
|
7,049
|
|||||
Property
and equipment, net
|
445
|
581
|
|||||
Investment
in Comverge
|
--
|
91,549
|
|||||
Investment
in Paketeria
|
1,212
|
2,270
|
|||||
Investment
in Local Power
|
--
|
268
|
|||||
Funds
in respect of employee termination benefits
|
1,568
|
1,455
|
|||||
Goodwill
|
97
|
101
|
|||||
Other
intangible assets, net
|
48
|
5
|
|||||
Other
assets
|
285
|
174
|
|||||
Total
assets
|
$
|
7,258
|
$
|
103,452
|
|||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Short-term
bank credit
|
$
|
462
|
$
|
94
|
|||
Current
maturities of long-term debt
|
26
|
48
|
|||||
Note
payable - related party
|
300
|
--
|
|||||
Trade
accounts payable
|
378
|
728
|
|||||
Accrued
payroll, payroll taxes and social benefits
|
478
|
822
|
|||||
Other
current liabilities
|
1,700
|
2,564
|
|||||
Total
current liabilities
|
3,344
|
4,256
|
|||||
Long-term
liabilities:
|
|||||||
Investment
in Comverge, net
|
1,824
|
--
|
|||||
Convertible
debt, net of discounts
|
--
|
5,041
|
|||||
Liability
for employee termination benefits
|
2,545
|
2,093
|
|||||
Deferred
taxes
|
--
|
21,522
|
|||||
Other
liabilities
|
6
|
--
|
|||||
Total
long-term liabilities
|
4,375
|
28,656
|
|||||
Shareholders’
equity:
|
|||||||
Common
stock - $0.01 par value per share:
|
|||||||
Authorized
- 20,000,000 shares; Issued -10,276,030 shares and 10,895,314 at
December 31, 2006 and September 30, 2007
|
102
|
108
|
|||||
Additional
paid-in capital
|
43,987
|
48,286
|
|||||
Warrants
|
888
|
1,540
|
|||||
Accumulated
deficit
|
(41,904
|
)
|
(31,679
|
)
|
|||
Treasury
stock, at cost - 777,371 shares for December 31, 2006 and September
30, 2007, respectively
|
(3,592
|
)
|
(3,592
|
)
|
|||
Accumulated
other comprehensive income
|
58
|
55,877
|
|||||
Total
shareholders’ equity (deficit)
|
(461
|
)
|
70,540
|
||||
Total
liabilities and shareholders’ equity
|
$
|
7,258
|
$
|
103,452
|
Nine
months ended
September
30,
|
Three
months ended
September
30,
|
||||||||||||
2006
|
2007
|
2006
|
2007
|
||||||||||
Sales:
|
|||||||||||||
Projects
|
$
|
2,203
|
$
|
2,699
|
$
|
682
|
1,412
|
||||||
Services
|
642
|
557
|
208
|
154
|
|||||||||
Other
|
41
|
59
|
33
|
29
|
|||||||||
Total
sales
|
2,886
|
3,315
|
923
|
1,595
|
|||||||||
Cost
of sales:
|
|||||||||||||
Projects
|
1,490
|
1,976
|
469
|
977
|
|||||||||
Services
|
547
|
525
|
178
|
145
|
|||||||||
Other
|
--
|
--
|
--
|
--
|
|||||||||
Total
cost of sales
|
2,037
|
2,501
|
647
|
1,122
|
|||||||||
Gross
profit
|
849
|
814
|
276
|
473
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development expenses
|
184
|
310
|
87
|
77
|
|||||||||
Selling,
marketing, general and administrative expenses
|
3,537
|
3,012
|
1,571
|
1,153
|
|||||||||
Total
operating expenses
|
3,721
|
3,322
|
1,658
|
1,230
|
|||||||||
Operating
loss
|
(2,872
|
)
|
(2,508
|
)
|
(1,382
|
)
|
(757
|
)
|
|||||
Finance
expense, net
|
(23
|
)
|
(2,827
|
)
|
(17
|
)
|
(716
|
)
|
|||||
Gain
on public offering of Comverge
|
--
|
16,169
|
--
|
--
|
|||||||||
Gain
on private placement of Paketeria
|
--
|
533
|
--
|
533
|
|||||||||
Other
income, net
|
330
|
--
|
--
|
--
|
|||||||||
Income
(loss) before taxes on income
|
(2,565
|
)
|
11,367
|
(1,399
|
)
|
(940
|
)
|
||||||
Taxes
on income
|
8
|
9
|
2
|
4
|
|||||||||
Income
(loss) from operations of the Company and its consolidated
subsidiaries
|
(2,573
|
)
|
11,358
|
(1,401
|
)
|
(944
|
)
|
||||||
Share
of losses in Comverge
|
(210
|
)
|
--
|
--
|
--
|
||||||||
Share
of losses in Paketeria
|
(250
|
)
|
(828
|
)
|
(250
|
)
|
(440
|
)
|
|||||
Net
income (loss) from continuing operations
|
(3,033
|
)
|
10,530
|
(1,651
|
)
|
(1,384
|
)
|
||||||
Net
income from discontinued operations, net of tax
|
78
|
--
|
--
|
--
|
|||||||||
Loss
on sale of discontinued operations and contract settlement, net of
tax
|
(2,298
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss)
|
$
|
(5,253
|
)
|
$
|
10,530
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
||
Basic
net income (loss) per share:
|
--
|
||||||||||||
Income
(loss) per share from continuing operations
|
$
|
(0.37
|
)
|
$
|
1.08
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
||
Discontinued
operations
|
(0.27
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss) per share - basic
|
$
|
(0.64
|
)
|
$
|
1.08
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
||
Diluted
net income (loss) per share:
|
|||||||||||||
Income
(loss) per share from continuing operations
|
$
|
(0.37
|
)
|
$
|
1.01
|
$
|
(0.20
|
)
|
--
|
||||
Discontinued
operations
|
(0.27
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss) per share -diluted
|
$
|
(0.64
|
)
|
$
|
1.01
|
$
|
(0.20
|
)
|
--
|
||||
Weighted
average number of shares outstanding -
|
|||||||||||||
Basic
|
8,163
|
9,723
|
8,164
|
10,063
|
|||||||||
Diluted
|
8,163
|
10,814
|
8,164
|
10,063
|
Number
of Shares
|
Common
Stock
|
Additional
Paid-In
Capital
|
Warrants
|
Accumulated
Deficit
|
Treasury
Stock
|
Accumulated
Other Comprehensive Income
|
Total
|
||||||||||||||||||
Balances
as of December
31, 2006
|
10,276
|
$
|
102
|
$
|
43,987
|
$
|
888
|
$
|
(41,904
|
)
|
$
|
(3,592
|
)
|
$
|
58
|
$
|
(461
|
)
|
|||||||
Net
income
|
--
|
--
|
--
|
--
|
10,530
|
--
|
--
|
10,530
|
|||||||||||||||||
FAS
115 adjustment on Comverge shares, net of deferred taxes
|
--
|
--
|
--
|
--
|
--
|
--
|
55,682
|
55,682
|
|||||||||||||||||
Differences
from translation of financial statements of subsidiaries
|
--
|
--
|
--
|
--
|
--
|
--
|
137
|
137
|
|||||||||||||||||
Comprehensive
income
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
66,349
|
|||||||||||||||||
FIN
48 adjustment
|
--
|
--
|
--
|
--
|
(305
|
)
|
--
|
--
|
(305
|
)
|
|||||||||||||||
Exercise
of options and warrants
|
619
|
6
|
1,129
|
(92
|
)
|
--
|
--
|
--
|
1,043
|
||||||||||||||||
Adjustment
of transaction costs of previous private placements
|
--
|
--
|
(15
|
)
|
--
|
--
|
--
|
--
|
(15
|
)
|
|||||||||||||||
Warrants
issued to placement agent with respect to private placement of
Debentures
|
--
|
--
|
--
|
213
|
--
|
--
|
--
|
213
|
|||||||||||||||||
Warrants
issued with respect to private placement of Debentures
|
--
|
--
|
--
|
531
|
--
|
--
|
--
|
531
|
|||||||||||||||||
Beneficial
conversion feature with respect to private placement of
Debentures
|
--
|
--
|
2,570
|
--
|
--
|
--
|
--
|
2,570
|
|||||||||||||||||
Stock
option compensation
|
--
|
--
|
615
|
--
|
--
|
--
|
--
|
615
|
|||||||||||||||||
Balances
as of September
30, 2007
|
10,895
|
$
|
108
|
$
|
48,286
|
$
|
1,540
|
$
|
(31,679
|
)
|
$
|
(3,592
|
)
|
$
|
55,877
|
$
|
70,540
|
Nine
months ended
September
30,
|
|||||||
2006
|
2007
|
||||||
Cash
flows provided by (used in) operating activities:
|
|||||||
Net
income (loss)
|
$
|
(5,253
|
)
|
$
|
10,530
|
||
Adjustments
to reconcile net income (loss) to net cash used
in operating activities:
|
|||||||
Depreciation
and amortization
|
165
|
118
|
|||||
Impairment
of software license
|
--
|
23
|
|||||
Share
in losses of Comverge
|
210
|
--
|
|||||
Share
in losses of Paketeria
|
52
|
779
|
|||||
Increase
(decrease) in liability for employee termination benefits
|
188
|
(167
|
)
|
||||
Amortization
of stock-based deferred compensation
|
1,346
|
615
|
|||||
Loss
on sale of Databit and contract settlement
|
2,298
|
--
|
|||||
Amortization
of beneficial conversion feature, debt origination costs and value
of
warrants in private placement of Debentures
|
--
|
2,516
|
|||||
Gain
on public offering of investment in Comverge
|
--
|
(16,169
|
)
|
||||
Gain
on private placement of Paketeria
|
--
|
(533
|
)
|
||||
Other
|
8
|
(6
|
)
|
||||
Change
in operating assets and liabilities:
|
|||||||
Decrease
(increase) in accounts receivable, unbilled work-in process and other
current and other assets
|
642
|
(504
|
)
|
||||
Increase
in inventory
|
(18
|
)
|
--
|
||||
Increase
(decrease) in accounts payable and other liabilities
|
(708
|
)
|
947
|
||||
Net
cash used in operating activities
|
(1,070
|
)
|
(1,851
|
)
|
|||
Cash
flows provided by (used in) investing activities:
|
|||||||
Release
of restricted cash
|
247
|
--
|
|||||
Release
of restricted cash (under agreement with a related party)
|
1,350
|
--
|
|||||
Investment
in Comverge
|
(210
|
)
|
--
|
||||
Loans
to and acquisition of note due from Paketeria
|
(863
|
)
|
(1,154
|
)
|
|||
Investment
in Local Power Inc.
|
--
|
(268
|
)
|
||||
Amounts
funded for employee termination benefits
|
(125
|
)
|
(160
|
)
|
|||
Utilization
of employee termination benefits
|
77
|
89
|
|||||
Acquisitions
of property and equipment
|
(119
|
)
|
(214
|
)
|
|||
Sale
of Databit Inc. - Appendix A
|
(911
|
)
|
--
|
||||
Net
cash used in investing activities
|
(554
|
)
|
(1,707
|
)
|
|||
Cash
flows provided by (used in) financing activities:
|
|||||||
Short-term
debt repayments, net
|
(130
|
)
|
(368
|
)
|
|||
Proceeds
from long-term debt
|
--
|
107
|
|||||
Proceeds
from convertible debentures with warrants net of transaction
costs
|
--
|
5,840
|
|||||
Repayments
of long-term debt
|
(112
|
)
|
(89
|
)
|
|||
Repayment
of related party note payable
|
--
|
(300
|
)
|
||||
Proceeds
from private placement of common stock, net of issuance
costs
|
2,623
|
--
|
|||||
Proceeds
from employee stock option and warrant exercises
|
160
|
1,043
|
|||||
Net
cash provided by financing activities
|
2,541
|
6,233
|
|||||
Net
increase in cash and cash equivalents
|
917
|
2,675
|
|||||
Cash
and cash equivalents at beginning of period
|
913
|
1,521
|
|||||
Cash
and cash equivalents at end of period
|
$
|
1,830
|
$
|
4,196
|
Non-cash
items:
|
|||||||
Accrued
expenses in respect of private placement of common stock and convertible
debentures
|
$
|
58
|
$
|
83
|
|||
Non-cash
financing and investing items
|
|||||||
Value
of beneficial conversion feature upon issuance of convertible
debentures
|
$
|
2,570
|
|||||
Unrealized
gain from Comverge shares
|
$
|
77,204
|
|||||
Conversion
of loans and notes receivable and accrued interest due from Paketeria
to
investment in Paketeria
|
$
|
1,190
|
|||||
Adjustment
of retained earnings and other current liabilities with respect to
the
adoption of FIN 48
|
$
|
305
|
|||||
Appendix
A
|
|||||||
Assets/liabilities
disposed of in disposition of Databit Inc. and contract
settlement:
|
|||||||
Current
assets
|
$
|
2,815
|
|||||
Non-current
assets
|
40
|
||||||
Debt
|
(20
|
)
|
|||||
Current
liabilities
|
(1,816
|
)
|
|||||
Stock
compensation costs
|
315
|
||||||
Unpaid
transaction costs in disposition of Databit and contract
settlement
|
63
|
||||||
Other
|
(10
|
)
|
|||||
Loss
on the sale of Databit and contract settlement
|
$
|
(2,298
|
)
|
||||
Net
cash used in business disposition
|
$
|
(911
|
)
|
Nine
months ended
September
30, 2007
|
Three
months ended
September
30, 2007
|
||||||
Sales
|
$
|
2,269
|
$
|
755
|
|||
Gross
loss
|
$
|
400
|
$
|
(210
|
)
|
||
Net
loss
|
$
|
(2,018
|
)
|
$
|
(1,123
|
)
|
Nine
months ended
September
30, 2007
|
Three
months ended
September
30, 2007
|
Period
from
August
7, 2006 to
September
30, 2006
|
||||||||
Equity
loss in Paketeria
|
$
|
(660
|
)
|
$
|
(367
|
)
|
$
|
(34
|
)
|
|
Amortization
expense associated with acquired non-compete and franchise agreements
and
change in value of options
|
(121
|
)
|
(58
|
)
|
(18
|
)
|
||||
Stock
compensation expense
|
(49
|
)
|
(17
|
)
|
(198
|
)
|
||||
Share
of losses in Paketeria
|
$
|
(828
|
)
|
$
|
(440
|
)
|
$
|
(250
|
)
|
Investment
balance as of December 31, 2006
|
$
|
1,212
|
||
Conversion
of debt and accrued interest in connection with private placement
(including transaction costs)
|
1,190
|
|||
Adjustment
of investment with respect to non-cash gain in connection with private
placement
|
533
|
|||
Amortization
of acquired non-compete and franchise agreements and change in value
of
options
|
(121
|
)
|
||
Cumulative
translation adjustment
|
116
|
|||
Company’s
share of Paketeria losses - period from January 1, 2007 to September
30,
2007
|
(660
|
)
|
||
Investment
balance as of September 30, 2007
|
$
|
2,
270
|
Number
of
Options
(in
shares)
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Life
|
Aggregate
Intrinsic
Value
|
||||||||||
Outstanding
at December 31, 2006
|
2,172,835
|
$
|
2.55
|
||||||||||
Granted
at market price
|
96,000
|
$
|
4.33
|
||||||||||
Granted
at discount to market price
|
79,000
|
$
|
3.50
|
||||||||||
Exercised
|
(563,168
|
)
|
$
|
1.58
|
$
|
1,959
|
|||||||
Forfeited
or expired
|
(179,167
|
)
|
$
|
3.60
|
|||||||||
Outstanding
at September 30, 2007
|
1,605,500
|
$
|
2.93
|
3.4
years
|
$
|
2,725
|
|||||||
Exercisable
at September 30, 2007
|
1,256,499
|
$
|
2.86
|
3.0
years
|
$
|
2,274
|
Volatility
|
50
|
%
|
||
Expected
term (years)
|
1.3
years
|
|||
Risk
free interest rate
|
4.9
|
%
|
||
Expected
dividend yield
|
0.0
|
%
|
|
|
Nine
months
ended
September
30,
2006
|
|
Nine
months
ended
September
30,
2007
|
|
Three
months
ended
September
30,
2006
|
|
Three
months
ended
September
30,
2007
|
|||||
Cost
of sales
|
$
|
22
|
$
|
22
|
$
|
1
|
$
|
--
|
|||||
Selling,
marketing, general and administrative expenses
|
1,005
|
543
|
565
|
191
|
|||||||||
Share
of losses in Paketeria
|
198
|
49
|
198
|
17
|
|||||||||
Loss
on sale of discontinued operations and contract settlement
|
315
|
--
|
--
|
--
|
|||||||||
Total
stock based compensation expense
|
$
|
1,540
|
$
|
614
|
$
|
764
|
$
|
208
|
Number
of
Warrants
(in
shares)
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Life
|
||||||||
Outstanding
at December 31, 2006
|
614,039
|
$
|
2.79
|
3.2
years
|
||||||
Granted
|
746,916
|
$
|
4.50
|
4.8
years
|
||||||
Exercised
|
(56,116
|
)
|
$
|
2.78
|
||||||
Forfeited
or expired
|
--
|
--
|
||||||||
Outstanding
and exercisable at September 30, 2007
|
1,304,839
|
$
|
3.77
|
3.7
years
|
· |
RT
Solutions whose activities are focused on two areas - naval solutions
and
other real-time and embedded hardware & software
development.
|
· |
OncoPro™
whose activities are comprised of the Company’s OncoPro™ solution state of
the art chemotherapy package for oncology and hematology
departments.
|
RT
Solutions
|
OncoPro™
|
Other
(*)
|
Total
|
||||||||||
Nine
months ended September 30, 2007:
|
|||||||||||||
Revenues
from external customers
|
$
|
2,321
|
$
|
403
|
$
|
591
|
$
|
3,315
|
|||||
Intersegment
revenues
|
--
|
--
|
--
|
--
|
|||||||||
Segment
gross profit
|
690
|
120
|
4
|
814
|
|||||||||
Segment
loss
|
(192
|
)
|
(270
|
)
|
(154
|
)
|
(616
|
)
|
|||||
Nine
months ended September 30, 2006:
|
|||||||||||||
Revenues
from external customers
|
1,983
|
468
|
435
|
2,886
|
|||||||||
Intersegment
revenues
|
--
|
--
|
--
|
--
|
|||||||||
Segment
gross profit
|
718
|
74
|
57
|
849
|
|||||||||
Segment
loss
|
(88
|
)
|
(187
|
)
|
(76
|
)
|
(351
|
)
|
|||||
Three
months ended September 30, 2007:
|
|||||||||||||
Revenues
from external customers
|
1,219
|
134
|
242
|
1,595
|
|||||||||
Intersegment
revenues
|
--
|
--
|
--
|
--
|
|||||||||
Segment
gross profit
|
429
|
12
|
32
|
473
|
|||||||||
Segment
income (loss)
|
41
|
(51
|
)
|
(24
|
)
|
(34
|
)
|
||||||
Three
months ended September 30, 2006:
|
|||||||||||||
Revenues
from external customers
|
649
|
154
|
120
|
923
|
|||||||||
Intersegment
revenues
|
--
|
--
|
--
|
--
|
|||||||||
Segment
gross profit
|
221
|
30
|
25
|
276
|
|||||||||
Segment
loss
|
(46
|
)
|
(74
|
)
|
(13
|
)
|
(133
|
)
|
Nine
months ended September 30,
|
Three
months ended September 30,
|
||||||||||||
2006
|
2007
|
2006
|
2007
|
||||||||||
Total
loss for reportable segments
|
$
|
(275
|
)
|
$
|
(462
|
)
|
$
|
(120
|
)
|
$
|
(10
|
)
|
|
Other
operational segment loss
|
(76
|
)
|
(154
|
)
|
(13
|
)
|
(24
|
)
|
|||||
Total
operating loss
|
(351
|
)
|
(616
|
)
|
(133
|
)
|
(34
|
)
|
|||||
Share
of losses in Paketeria
|
(52
|
)
|
(828
|
)
|
(52
|
)
|
(440
|
)
|
|||||
Share
of losses in Comverge
|
(210
|
)
|
--
|
--
|
--
|
||||||||
Gain
recorded on Comverge public offering
|
--
|
16,169
|
--
|
--
|
|||||||||
Gain
recorded on Paketeria private placement
|
--
|
533
|
--
|
533
|
|||||||||
Net
loss of corporate headquarters and other unallocated
costs*
|
(2,420
|
)
|
(4,728
|
)
|
(1,466
|
)
|
(1,443
|
)
|
|||||
Net
income (loss) from continuing operations
|
(3,033
|
)
|
10,530
|
(1,651
|
)
|
(1,384
|
)
|
||||||
Discontinued
operations
|
78
|
--
|
--
|
--
|
|||||||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
--
|
--
|
--
|
||||||||
Total
consolidated net income (loss)
|
$
|
(5,253
|
)
|
$
|
10,530
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
*
Includes $2,516 and $570 of non-cash interest expense during the
nine and
three months ended September 30, 2007, respectively, with respect
to the
private placement of Debentures (see Note
8).
|
Nine
months ended September 30,
|
Three
months ended September 30,
|
||||||||||||
2006
|
2007
|
2006
|
2007
|
||||||||||
Basic:
|
|||||||||||||
Net
income (loss) from continuing operations
|
$
|
(3,033
|
)
|
$
|
10,530
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
||
Discontinued
operations
|
(2,220
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss)
|
$
|
(5,253
|
)
|
$
|
10,530
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
||
Weighted
average number of shares outstanding
|
8,163
|
9,723
|
8,164
|
10,063
|
|||||||||
Net
income (loss) per share from continuing operations
|
$
|
(0.37
|
)
|
$
|
1.08
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
||
Discontinued
operations per share
|
(0.27
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss) per share
|
$
|
(0.64
|
)
|
$
|
1.08
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
||
Diluted:
|
|||||||||||||
Net
income (loss) from continuing operations
|
$
|
(3,033
|
)
|
$
|
10,530
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
||
Plus
tax-effected interest expense related to Debentures
|
--
|
347
|
--
|
--
|
|||||||||
Net
income (loss) assuming dilutions of continuing operations
|
(3,033
|
)
|
10,847
|
(1,651
|
)
|
(1,384
|
)
|
||||||
Discontinued
operations
|
(2,220
|
)
|
--
|
--
|
--
|
||||||||
Net
income (loss)
|
$
|
(5,253
|
)
|
$
|
10,847
|
$
|
(1,651
|
)
|
$
|
(1,384
|
)
|
||
Weighted
average number of shares outstanding
|
8,163
|
9,723
|
8,164
|
10,063
|
|||||||||
Effect
of dilutive securities:
|
|||||||||||||
Debentures
|
--
|
163
|
--
|
--
|
|||||||||
Stock
options and warrants
|
--
|
928
|
--
|
--
|
|||||||||
Weighted
average number of shares outstanding assuming dilution
|
8,163
|
10,814
|
8,164
|
10,063
|
|||||||||
Diluted
net income (loss) per share from continuing operations
|
$
|
(0.37
|
)
|
$
|
1.01
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
||
Discontinued
operations per share
|
(0.27
|
)
|
--
|
--
|
--
|
||||||||
Diluted
net income (loss) per share
|
$
|
(0.64
|
)
|
$
|
1.01
|
$
|
(0.20
|
)
|
$
|
(0.14
|
)
|
Nine
months ended September 30,
|
|
Three
months ended September 30,
|
|
||||||||||||||||||||||||||||
|
|
2006
|
|
2007
|
|
Change
|
|
2006
|
|
2007
|
|
Change
|
|||||||||||||||||||
|
($,000)
|
|
%
of
sales
|
|
($,000)
|
|
%
of
sales
|
|
%
of
2006
|
|
($,000)
|
|
%
of
sales
|
|
($,000)
|
|
%
of
sales
|
|
%
of
2006
|
||||||||||||
Sales
|
$
|
2,886
|
100
|
%
|
$
|
3,315
|
100
|
%
|
15
|
%
|
$
|
923
|
100
|
%
|
$
|
1,595
|
100
|
73
|
|||||||||||||
Cost
of sales
|
2,037
|
71
|
2,501
|
75
|
23
|
647
|
70
|
1,122
|
70
|
73
|
|||||||||||||||||||||
Gross
profit
|
849
|
29
|
814
|
25
|
(4
|
)
|
276
|
30
|
473
|
30
|
71
|
||||||||||||||||||||
R&D
expenses
|
184
|
6
|
310
|
9
|
68
|
87
|
9
|
77
|
5
|
(11
|
)
|
||||||||||||||||||||
SMG&A
expenses
|
3,537
|
123
|
3,012
|
91
|
(15
|
)
|
1,571
|
170
|
1,153
|
72
|
(27
|
)
|
|||||||||||||||||||
Operating
loss
|
(2,872
|
)
|
(100
|
)
|
(2,508
|
)
|
(76
|
)
|
(13
|
)
|
(1,382
|
)
|
(150
|
)
|
(757
|
)
|
(47
|
)
|
(45
|
)
|
|||||||||||
Finance
expense, net
|
(23
|
)
|
(1
|
)
|
(2,827
|
)
|
(85
|
)
|
12,191
|
(17
|
)
|
(2
|
)
|
(716
|
)
|
(45
|
)
|
4,112
|
|||||||||||||
Gain
on public offering of Comverge
|
--
|
--
|
16,169
|
488
|
--
|
--
|
--
|
--
|
--
|
||||||||||||||||||||||
Gain
on private placement of Paketeria
|
--
|
--
|
533
|
16
|
--
|
--
|
533
|
33
|
|||||||||||||||||||||||
Other
income, net
|
330
|
11
|
--
|
(100
|
)
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||||||||||
Income
(loss) before taxes on income
|
(2,565
|
)
|
(89
|
)
|
11,367
|
343
|
543
|
(1,399
|
)
|
(152
|
)
|
(940
|
)
|
(59
|
)
|
33
|
|||||||||||||||
Taxes
on income
|
(8
|
)
|
0
|
(9
|
)
|
0
|
13
|
(2
|
)
|
0
|
(4
|
)
|
0
|
100
|
|||||||||||||||||
Income
(loss) from operations of the Company and its consolidated
subsidiaries
|
(2,573
|
)
|
(89
|
)
|
11,358
|
343
|
541
|
(1,401
|
)
|
(152
|
)
|
(944
|
)
|
(59
|
)
|
33
|
|||||||||||||||
Share
in losses in Paketeria
|
(250
|
)
|
(9
|
)
|
(828
|
)
|
(25
|
)
|
231
|
(250
|
)
|
(27
|
)
|
(440
|
)
|
(28
|
)
|
76
|
|||||||||||||
Share
in losses in Comverge
|
(210
|
)
|
(7
|
)
|
--
|
--
|
(100
|
)
|
--
|
--
|
--
|
--
|
--
|
||||||||||||||||||
Net
loss from continuing operations
|
(3,033
|
)
|
(105
|
)
|
10,530
|
318
|
447
|
(1,651
|
)
|
(179
|
)
|
(1,384
|
)
|
(87
|
)
|
16
|
|||||||||||||||
Net
income from discontinued operations, net of tax
|
78
|
3
|
--
|
--
|
(100
|
)
|
--
|
--
|
--
|
--
|
--
|
||||||||||||||||||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
(80
|
)
|
--
|
--
|
(100
|
)
|
--
|
--
|
--
|
--
|
--
|
||||||||||||||||||
Net
income (loss)
|
$
|
(5,253
|
)
|
(182
|
)
|
$
|
10,530
|
318
|
300
|
$
|
(1,651
|
)
|
(179
|
)
|
$
|
(1,384
|
)
|
(87
|
)
|
16
|
Cash
Payments Due During Year Ending September 30,
|
||||||||||||||||
(amounts
in thousands)
|
||||||||||||||||
Contractual
Obligations
|
Total
|
2008
|
2009-2010
|
2011-2012
|
2013
and thereafter
|
|||||||||||
Long-term
debt
|
$
|
6,886
|
$
|
--
|
$
|
--
|
$
|
6,886
|
$
|
--
|
||||||
Operating
leases (1)
|
752
|
453
|
299
|
--
|
--
|
|||||||||||
Potential
severance obligations to Israeli employees (2)
|
2,378
|
285
|
--
|
--
|
2,093
|
|||||||||||
Investment
in EnerTech Capital Partners III L.P. (3)
|
5,000
|
5,000
|
--
|
--
|
--
|
|||||||||||
Investor
relations
|
12
|
12
|
--
|
--
|
--
|
|||||||||||
Total
contractual cash obligations
|
$
|
15,028
|
$
|
5,750
|
$
|
299
|
$
|
6,886
|
$
|
2,093
|
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
32.1
|
Certification
of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
|
32.2
|
Certification
of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
ACORN FACTOR, INC. | ||
|
|
|
Dated: November 19, 2007 | By: | /s/ Michael Barth |
Michael
Barth
Chief
Financial Officer
|
||